Dr. G. H. Tichenor Antiseptic Co. v. United States

77 F. Supp. 288, 36 A.F.T.R. (P-H) 1502, 1948 U.S. Dist. LEXIS 2663
CourtDistrict Court, E.D. Louisiana
DecidedMarch 22, 1948
DocketCiv. A. No. 1332
StatusPublished
Cited by1 cases

This text of 77 F. Supp. 288 (Dr. G. H. Tichenor Antiseptic Co. v. United States) is published on Counsel Stack Legal Research, covering District Court, E.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Dr. G. H. Tichenor Antiseptic Co. v. United States, 77 F. Supp. 288, 36 A.F.T.R. (P-H) 1502, 1948 U.S. Dist. LEXIS 2663 (E.D. La. 1948).

Opinion

BORAH, District Judge.

This suit by plaintiff taxpayer was brought against the United States of America under and pursuant to the provisions of Title 28 U.S.C.A. § 41(20) to recover the sum of $548.25 alleged to have been overpaid as excess profits tax for the calendar year 1940.

The action is based on the ground that the Commissioner of Internal Revenue in determining the taxpayer’s excess profits tax for the year' 1940 under the invested capital method, pursuant to Section 718 of the Internal Revenue Code, 26 U.S.C.A. Int.Rev.Code. § 718, erred in valuing at $90,000 a certain contract under which the taxpayer manufactured a medicinal compound instead of allowing a value of at least $284,375.

The facts are found to be as follows: Findings of Fact

1. Dr. George H. Tichenor, a resident of the City of New Orleans, was the originator and patentee of a medical compound known as “Dr. G. H. Tichenor’s Antiseptic Refrigerant”, registered in the United States Patent Office in the year 1882, and registry renewed from time to time.

2. On May 9, 1893, Dr. Tichenor, by written contract conveyed to J. M. Sherousse and Mrs. A. L. Baldwin the exclusive right of sale and the sole control and management of the compound together with such of his personal services as might be necessary in the supervision and manufacture of the refrigerant for a period of sixteen years from May 1, 1893. Under the agreement Dr. Tichenor was to receive for his services $4,000 per annum and a royalty of 2% of the gross sales in excess of $50,000 annually. On August 14, 1895, the expiration date of the contract was extended from May 1, 1909 to May 1, 1916.

3. On June 29, 1905, A. D. Parker and W. R. Irby, both residents of the City of New Orleans, purchased the unexpired term of ten years and ten months of the aforesaid contract from Sherousse and Mrs. Baldwin for the sum of $50,000 and the assumption of all the obligations of the aforesaid contract.

4. On the same day, to-wit, June 29, 1905, Parker and Irby secured from Dr. G. H. Tichenor an extension of their aforesaid contract rights to July 1, 1935. In consideration they agreed to pay Dr. Tichenor $5,000 per annum for his services in supervising the manufacture of the compound and in addition to pay him from July 1, 1916, a royalty of 2% of the gross sales in excess of $50,000.

5. On June 30, 1905, pursuant to the agreement of June 15, 1905, the taxpayer corporation was formed by Parker and Irby who subscribed to 27 of the original 30 shares.

6. By a contract dated July 8, 1905, Parker and Irby transferred to the taxpayer corporation all their contract rights in and to the contracts which they had acquired from Sherousse, Mrs. Baldwin and Dr. Tichenor, as aforesaid, for $500,-000, represented by $3,000 in cash and 4970 shares of par value $100.00 each, of the corporation’s capital stock.

7. Prior to January 22, 1929, and in accordance with the terms of the contract of June 29, 1905, Dr. Tichenor transferred all his right to trade-marks and formulas, and any rights whatsoever [291]*291pertaining to the refrigerant to The Dr. G. H. Tichenor Company, Ltd., a corporation organized by him.

8. By contract dated January 22, 1909, the taxpayer corporation secured from The Dr. G. H. Tichenor Company, Ltd., to which Dr. Tichenor had transferred his formula and patent rights, an extension of its aforesaid contract rights to July 1, 1985, with the same obligations as to annual compensation and on the further condition that royalties would be paid from January 1, 1909 instead of July 1, 1916.

9. For excess profits tax purposes the taxpayer corporation adopted the invested capital method for reporting its income. In its return for the year 1940 the taxpayer under such method evaluated the interest it acquired from Parker and Irby on July 8, 1905 at $500,000. It claimed an annual amortization of $6250 for a total of 34% years, or a total of $215,625 and a balance of $284,375 was thus reported as equity invested capital for 1940.

10. In the audit of the taxpayer’s return the Commissioner of Internal Revenue adjusted the value of the contract from $284,375 to $90,000. The adjustment caused the additional tax of $548.25 which was paid on October 17, 1941, and is now sought to be recovered in this suit.

The statutes and’ regulations involved are set forth in the margin.1

In its claim for refund and in the complaint, the taxpayer contended that the contract in suit has a value of $284,375. But apart from certain documentary evidence hereinafter referred to, the evidence offered with respect to valuation was that stock having a par value of $500,000 was issued in exchange for the the contract, [292]*292and that the men who controlled the corporation and fixed such value were good and able business men. On the basis of this showing the taxpayer maintains that because the interested parties, some forty-three years before, fixed the value in the manner and at the amount of the par value of the stock as above stated, the Commissioner was bound to do likewise. We think differently.

The par value of a stock does not establish its true worth. And “the fact that stock of a certain par value is given for something is no evidence of the actual value of that thing for the purpose of computing invested capital.” Appeal of Pacific Baking Company, 2 B.T.A. 391, 392. Furthermore, the valuation claimed by the taxpayer is clearly erroneous since it is the alleged value as of 1940 based on an original alleged value of $500,000. The applicable regulations clearly provide that in evaluating property the basis to the taxpayer is the unadjusted basis or cost. They hold further that if the basis to the taxpayer is cost and stock was issued for the property, the cost is the fair market value of such stock at the time of its issuance. If the stock had no established market value at the time of the exchange, then it is necessary to determine the fair market value of the property itself. In McKinney v. Commissioner of Internal Revenue, 32 B.T.A. 450, 456, affirmed 10 Cir., 87 F.2d 811, the Board of Tax Appeals had occasion to consider the well settled rule with regard to the cost of property acquired by a corporation for its stock and said:

“It is well settled that the cost to a corporation of the property acquired through the issuance of its capital stock is the fair market value of such capital stock on the date issued, and where all of the capital stock of a corporation is issued for property and there is no other method of measuring the fair market value of the stock so issued, such fair market value [293]*293on that date may properly be determined to be the equivalent of the fair market value of the property received. Reliance Investment Co. v. C. I. R., 22 B.T.A. 1287; Meade Realty Co. v. C. I. R., 21 B.T.A. 1062; L. H. Philo Corporation v. C. I. R., 16 B.T.A. 130; John Glackner Realty Corp. v. C. I. R., 11 B.T.A. 151; Realty Sales Co. v. C. I. R., 10 B.T.A. 1217.”

In the case at bar the basic date is July 8, 1905, the date on which the taxpayer acquired the contract from Parker and Irby. Inasmuch as stock was issued for the property or contract and the . stock was closely held and had no established market value, the taxpayer was obliged to prove the fair market value of the contract itself as of July 8, 1905.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Tennessee Products Corp. v. United States
107 F. Supp. 578 (Court of Claims, 1952)

Cite This Page — Counsel Stack

Bluebook (online)
77 F. Supp. 288, 36 A.F.T.R. (P-H) 1502, 1948 U.S. Dist. LEXIS 2663, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dr-g-h-tichenor-antiseptic-co-v-united-states-laed-1948.